However, alterations in TLR4 expression in patients with PD had not yet been demonstrated, and it was unclear whether there are any endogenous molecules capable of inducing DA neurodegeneration through microglial activation via TLR4 induction, but in the absence of any direct neurotoxic effect. This evidence concerns the gene TLR4 and Parkinson disease.